BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 5590663)

  • 1. [Hormone determinations during 17-hydroxyprogesterone-capronate therapy].
    Sas M; Morvay J
    Zentralbl Gynakol; 1967 Oct; 89(43):1585-91. PubMed ID: 5590663
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of orchidectomy on the excretion of testosterone, 17-ketosteroids, estrogens, pregnanediol, 17-hydroxycorticosteroids and gonadotropins in urine].
    Klosterhalfen H; Voigt KD; Tamm J
    Urol Int; 1965; 20(6):364-75. PubMed ID: 5873139
    [No Abstract]   [Full Text] [Related]  

  • 3. [Endocrine environment of chorionic tumor].
    Okamoto M
    Nihon Sanka Fujinka Gakkai Zasshi; 1971 May; 23(5):432-40. PubMed ID: 5104366
    [No Abstract]   [Full Text] [Related]  

  • 4. [Urinary excretion of estrogenic fractions, pregnanediol, free and total 17-hydroxycorticosteroids and 17-ketosteroids in women with uterine myoma].
    Sieroń G; Buntner B
    Ginekol Pol; 1971; 42(3):343-9. PubMed ID: 5554646
    [No Abstract]   [Full Text] [Related]  

  • 5. [3. Change of ovarian function with age].
    Matsumoto S; Adachi H; Mizutani S; Kurobe I; Takahashi H
    Nihon Naibunpi Gakkai Zasshi; 1969 Oct; 45(7):686-9 passim. PubMed ID: 5388346
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of steroid homeostasis in the pathogenesis of cancer of the uterine cervix].
    Cherniavskaia GIa; Il'ubskaia EG; Tiutiunova AM; Nerodo GA; Rozenko LIa
    Vopr Onkol; 1982; 28(9):91-4. PubMed ID: 7123889
    [No Abstract]   [Full Text] [Related]  

  • 7. [Excretion of follicle-stimulating and steroid hormones in patients with uterine cancer during treatment with 17-hydroxyprogesterone caproate].
    Sharoukhova KS; Vershinina GN; Murav'eva NI; Smirnova KD; Goncharova MG
    Akush Ginekol (Mosk); 1970 Oct; 46(10):9-13. PubMed ID: 5519750
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of Ro 4-8347 administered from the 5th to 25th of the cycle to women with regular cycle with ovulation].
    Guéguen J
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):428-40. PubMed ID: 5510169
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the excretion of estrogen, gonadotropins, 17-ketosteroids and 17-hydroxycorticosteroids in women with diffuse alopecia].
    Rubisz-Brzezińska J; Zych F
    Przegl Dermatol; 1971; 58(4):413-20. PubMed ID: 5098521
    [No Abstract]   [Full Text] [Related]  

  • 10. Gonadotropin and steroid hormone excretion in trophoblastic neoplasia.
    Ishizuka N; Okamoto M; Tomoda Y
    Obstet Gynecol; 1973 Jul; 42(1):1-11. PubMed ID: 4352641
    [No Abstract]   [Full Text] [Related]  

  • 11. [FSH and steroid hormone excretion in breast cancer during chemotherapy].
    Sokolova VD; Sharoukhova KS; Goncharova MG; Murav'eva NI; Smirnova KD
    Vopr Onkol; 1972; 18(10):19-22. PubMed ID: 4197020
    [No Abstract]   [Full Text] [Related]  

  • 12. [Indication and significance of hormone-analysis in gynecology].
    Runnebaum B
    Gynakol Rundsch; 1973; 13():Suppl 1:24-33. PubMed ID: 4798929
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hormone changes induced by administration of clomiphene in amenorrheic women].
    Silvestrini F; Faglia G; Norbiato G; D'Alonzo R; Gelli D; Liuzzi A; Neri V
    Folia Endocrinol; 1967 Feb; 20(1):29-47. PubMed ID: 6072788
    [No Abstract]   [Full Text] [Related]  

  • 14. [Masculinizing tumors of the adrenal cortex in children before puberty].
    Decourt J; Anoussakis C
    Sem Hop; 1969 Mar; 45(13):817-26. PubMed ID: 4327255
    [No Abstract]   [Full Text] [Related]  

  • 15. [Risks of ovarian overstimulation by administration of clomiphene and gonadotropins for ovulation stimulation].
    Hammerstein J
    Geburtshilfe Frauenheilkd; 1967 Dec; 27(12):1125-51. PubMed ID: 5627491
    [No Abstract]   [Full Text] [Related]  

  • 16. Influences of long-term use of intrauterine devices on reproductive organs.
    Matsumoto S; Ito T; Shiozaki T; Iijima Y; Tamada T
    Int J Fertil; 1968; 13(4):326-31. PubMed ID: 5700388
    [No Abstract]   [Full Text] [Related]  

  • 17. [Excretion of steroid hormones in women with luteal insufficiency].
    Vrtílek V; Drác P
    Cesk Gynekol; 1966 Aug; 31(6):504-7. PubMed ID: 5925819
    [No Abstract]   [Full Text] [Related]  

  • 18. [Gonadotropin and steroid hormone excretion during treatment with 1-alpha-methyl-5-alpha-androstan-17-beta-ol-3-one (mesterolone)].
    Laschet U; Laschet L; Paarmann HF
    Arzneimittelforschung; 1966 Apr; 16(4):469-71. PubMed ID: 6014252
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary hormone metabolite levels in patients with cancer of the breast, prostate and lung.
    Marmorston J
    Ann N Y Acad Sci; 1966 Jan; 125(3):959-73. PubMed ID: 5223416
    [No Abstract]   [Full Text] [Related]  

  • 20. [Importance of hormone determinations in gynecology and obstetrics].
    Runnebaum B; Holzmann K; Zander J
    Munch Med Wochenschr; 1971 May; 113(20):762-71. PubMed ID: 5108354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.